Streetbeat News

Products Services

PEN

Penumbra, Inc. has completed enrollment for its THUNDER IDE study, which evaluates the safety and efficacy of its latest thrombectomy technology for acute ischemic stroke treatment.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:04 pm

AMD

AMD has launched the Alveo UL3422 accelerator card, designed for ultra-low latency electronic trading applications. This new product is optimized for rack space and cost, and is aimed at trading firms, market makers, and financial institutions.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:03 pm

FLEX

Flex and JetCool have partnered to develop liquid cooling-ready servers for AI and high-density workloads, addressing the demand from hyperscalers and enterprise customers. The servers will use JetCool's microconvective liquid cooling technology and comply with Open Compute Project specifications.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:02 pm

GEHC

GE HealthCare has launched the Versana Premier, a new multi-purpose ultrasound system designed to enhance clinical efficiency and accuracy with advanced imaging and AI-enabled productivity tools. This system aims to simplify workflows for healthcare professionals across various specialties.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:02 pm

STLA

Stellantis CEO Carlos Tavares stated that Chinese carmakers are unlikely to produce cars in Germany, France, or Italy due to cost disadvantages, particularly energy costs. He also mentioned that EU duties on Chinese EVs could lead to accelerated plant closures by European automakers.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:47 pm

BYDDF

BYDDY

BYD criticized the EU's proposed tariffs on Chinese-made EVs at the Paris Car Show, warning of increased costs and market impact. The tariffs aim to counter alleged unfair subsidies from China, but have sparked debate and concerns over trade tensions.

Portfolio Pulse from Benzinga Neuro

October 14, 2024 | 12:45 pm

GSK

GSK's phase 3 trials for depemokimab show promising results in reducing nasal polyp size and nasal obstruction in patients with chronic rhinosinusitis. The trials met their primary endpoints, and further data analysis is ongoing. GSK's stock is up 0.80% in premarket trading.

Portfolio Pulse from Vandana Singh

October 14, 2024 | 12:39 pm

IPW

iPower Inc. (NASDAQ:IPW) has expanded its SuperSuite's U.S. sales channels by launching on AliExpress, enhancing its reach and providing supply chain partners access to another major U.S. marketplace.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:35 pm

DWAC

Trump Media has announced the launch of its new streaming service, Truth+ TV. This move is part of the company's strategy to expand its media offerings.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:34 pm

ORCL

Oracle has launched Oracle Health Clinical Data Exchange, a cloud-based solution to automate and streamline medical claims processing, reducing manual processes and costs for healthcare providers and payers.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:31 pm